Theravance Biopharma Inc
TBPH
$17.03+0.00%
End of day · as of Sep 27, 2026, 8:01 PM ET
Mkt cap
$861.45M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$20.73M
EPS (H1 2026)
$-0.21
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-28.45%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported TBPH revenue for 2026-06-30 was $20.7M. Net income was -$5.9M. Revenue was up 17.1% from 2026-03-31 to 2026-06-30. TBPH currently screens at market cap $861.5M.
Use this TBPH research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full TBPH income, balance, and cash tables.
Theravance Biopharma Inc (TBPH) is a biotechnology company in the Healthcare sector.
Latest cached Theravance Biopharma Inc (TBPH) revenue for Jun 30, 2026 was $20.7M. Net income was -$5.9M. Statements: https://lician.com/financials/tbph
Theravance Biopharma Inc (TBPH) market capitalization is $861.5M on the latest cached snapshot.
Theravance Biopharma Inc (TBPH) cached previous close $17.03; day range $17.03 – $17.03. Session quote: https://lician.com/quote/tbph
Theravance Biopharma Inc (TBPH) latest cached earnings event is "TBPH earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TBPH filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/tbph